Literature DB >> 8743966

Progesterone as a neurosteroid: actions within the nervous system.

E E Baulieu1, M Schumacher, H Koenig, I Jung-Testas, Y Akwa.   

Abstract

1. Some progesterone is synthesized within both the central and the peripheral nervous systems, where it regulates neurotransmission and important glial functions, such as the formation of myelin. Progesterone can thus be designated a "neurosteroid." 2. Steroids act not only on the brain, but also on peripheral nerves, which offer many advantages to study the biological significance of locally produced neurosteroids: their remarkable plasticity and regenerative capacity and their relatively simple structure. 3. By using the regenerating mouse sciatic nerve as a model, we have shown that progesterone synthesized by rat Schwann cells promotes the formation of new myelin sheaths. Progesterone also increases the number of myelinated axons when added at a low concentration to cocultures of Schwann cells and sensory neurons. 4. These findings show a function on myelination for locally produced progesterone and suggest a new pharmacological approach of myelin repair.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743966     DOI: 10.1007/bf02088173

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  45 in total

1.  Behavioral effects of progesterone associated with rapid modulation of oxytocin receptors.

Authors:  M Schumacher; H Coirini; D W Pfaff; B S McEwen
Journal:  Science       Date:  1990-11-02       Impact factor: 47.728

2.  Neurosteroids in rat sciatic nerves and Schwann cells.

Authors:  Y Akwa; M Schumacher; I Jung-Testas; E E Baulieu
Journal:  C R Acad Sci III       Date:  1993

3.  Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury.

Authors:  L Guth; Z Zhang; E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

4.  Differential responses of expressed recombinant human gamma-aminobutyric acidA receptors to neurosteroids.

Authors:  N C Lan; K W Gee; M B Bolger; J S Chen
Journal:  J Neurochem       Date:  1991-11       Impact factor: 5.372

5.  Glucocorticoids enhance the potency of Schwann cell mitogens.

Authors:  T J Neuberger; O Kalimi; W Regelson; M Kalimi; G H De Vries
Journal:  J Neurosci Res       Date:  1994-06-15       Impact factor: 4.164

6.  Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A.

Authors:  B B Roa; C A Garcia; L Pentao; J M Killian; B J Trask; U Suter; G J Snipes; R Ortiz-Lopez; E M Shooter; P I Patel; J R Lupski
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

7.  Rapid metabolism of fatty acids covalently bound to myelin proteolipid protein.

Authors:  O A Bizzozero; L K Good
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

8.  Pregnenolone and its sulfate ester in the rat brain.

Authors:  C Corpéchot; M Synguelakis; S Talha; M Axelson; J Sjövall; R Vihko; E E Baulieu; P Robel
Journal:  Brain Res       Date:  1983-06-27       Impact factor: 3.252

9.  Progesterone synthesis and myelin formation by Schwann cells.

Authors:  H L Koenig; M Schumacher; B Ferzaz; A N Thi; A Ressouches; R Guennoun; I Jung-Testas; P Robel; Y Akwa; E E Baulieu
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

10.  Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density.

Authors:  Y Akwa; N Sananès; M Gouézou; P Robel; E E Baulieu; C Le Goascogne
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  16 in total

Review 1.  Gonadal steroids and neuronal function.

Authors:  R Alonso; I López-Coviella
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 2.  Management of the extremely preterm infant: is the replacement of estradiol and progesterone beneficial?

Authors:  A Trotter; L Maier; F Pohlandt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Progestin concentrations are increased following paced mating in midbrain, hippocampus, diencephalon, and cortex of rats in behavioral estrus, but only in midbrain of diestrous rats.

Authors:  Cheryl A Frye; Madeline E Rhodes
Journal:  Neuroendocrinology       Date:  2006-10-04       Impact factor: 4.914

Review 4.  Neuroprotection by ovarian hormones in animal models of neurological disease.

Authors:  Gloria E Hoffman; Istvan Merchenthaler; Susan L Zup
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

5.  Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones.

Authors:  H Wang; K L Napoli; H W Strobel
Journal:  Mol Cell Biochem       Date:  2000-10       Impact factor: 3.396

Review 6.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

7.  Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2.

Authors:  Lifei Liu; Junming Wang; Liqin Zhao; Jon Nilsen; Kelsey McClure; Karren Wong; Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

Review 8.  Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury.

Authors:  Mohammad Khaksari; Zahra Soltani; Nader Shahrokhi
Journal:  Transl Stroke Res       Date:  2017-11-19       Impact factor: 6.829

Review 9.  Gender and the injured brain.

Authors:  Kamila Vagnerova; Ines P Koerner; Patricia D Hurn
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

Review 10.  Progesterone receptors: form and function in brain.

Authors:  Roberta Diaz Brinton; Richard F Thompson; Michael R Foy; Michel Baudry; Junming Wang; Caleb E Finch; Todd E Morgan; Christian J Pike; Wendy J Mack; Frank Z Stanczyk; Jon Nilsen
Journal:  Front Neuroendocrinol       Date:  2008-02-23       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.